# Session log - July 14-15, 2026 (continued from earlier same-day log)

## What was accomplished

- Rebuilt the wide comorbidity matrix locally with the corrected classification codes from issue #8 (confirmed via console checks that the 2 affected patients still correctly show RMD=1, since each has a second independent RMD diagnosis).
- Closed issue #11: joined the comorbidity matrix to the main patient file (left join, main file as base, NA->0 fill). Confirmed row count matches exactly (1,304 in, 1,304 out), no NAs remaining.
- Closed issue #10: sanity-check folded into issue #11's work. Confirmed the drop from the matrix's raw tallies (186/22/131/240 across 461 patients) to the post-join tallies (167/18/113/222) is fully explained by 47 patients who appear in the medical history file but not the main file (screening-stage patients never randomized) - a known, documented, expected data quality pattern, not a bug.
- Closed issue #12: descriptive statistics. **This answers research question 1.**

## Research question 1 - answered

"What was the comorbidity burden in the S1404 trial?"

31.8% of the 1,301 randomized patients (414 patients) had at least one of the four tracked comorbidities. Most of those had exactly one (24.4% of the full population has 1, only 7.4% have 2 or more). By category: rheumatic/musculoskeletal disorder was most common (17.1%), then cardiovascular disease (12.8%), type 2 diabetes (8.7%), and chronic obstructive pulmonary disease least common (1.4%). The sensitivity version (different assumption about 2 patients' osteoarthritis/gout ongoing status) barely moves these numbers - only rheumatic/musculoskeletal disorder shifts, by 2 patients. Comorbidity burden is balanced across the two treatment arms, consistent with randomization.

## Where things stand

Phase 1 issues closed: #7, #8, #9, #10, #11, #12, #18. That is every issue that does not depend on the selective serotonin reuptake inhibitor (SSRI) variable.

Still blocked, all downstream of issue #19 (locate/derive the SSRI variable):
- #13: Cox regression scaffolding
- #15: baseline unadjusted Cox model
- #14: comorbidity-adjusted Cox model
- #16: compare results and answer research question 2

## The SSRI variable blocker - fully exhausted from the data side

As of this session, every angle available without contacting anyone has been checked and ruled out:
- Main patient file: 14 columns, none related to selective serotonin reuptake inhibitors (confirmed twice, including a fresh console reload).
- Medical history file (both the cleaned unique list and the full raw file): searched for the term "SSRI" and every common brand/generic selective serotonin reuptake inhibitor name - zero matches in either.
- The trial protocol confirms why: concomitant medications (which would include selective serotonin reuptake inhibitor status) were collected on a separate case report form, the "S1404 Concomitant Medications Form," submitted every treatment cycle - entirely distinct from the Medical History Form, which is the only form that made it into the two files currently available.

This is not solvable by searching harder or writing more R code - the data genuinely is not in either available file. The only remaining paths are: (a) locate a supplemental data extract elsewhere, if one exists and is accessible without going through the mentor, or (b) ask the mentor for the missing form's data extract, which has not been done yet since the person doing this project wants to fully exhaust independent options first.

## For the next session (read this first)

Start here: has the selective serotonin reuptake inhibitor (SSRI) variable been located yet (issue #19)? If not, that is still the very first thing to resolve before anything else, since it blocks every remaining issue. If it has been resolved, skip straight to issue #13 (Cox regression scaffolding).

If picking this up fresh, a simple prompt like "I need to get started on today's work, what's the first thing on the agenda" is enough - the answer will be pulled from this log and the open GitHub issues, no need to re-explain any project context.
